会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 9. 发明申请
    • METHOD FOR THE CONTROL OF HYPERLIPIDEMIA
    • 控制高脂血症的方法
    • WO1990000897A1
    • 1990-02-08
    • PCT/US1989003246
    • 1989-07-27
    • UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILLNORTH CAROLINA CENTRAL UNIVERSITY
    • UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILLNORTH CAROLINA CENTRAL UNIVERSITYIZYDORE, Robert, A.HALL, Iris, H.
    • A61K31/53
    • A61K31/53A61K31/41
    • The invention provides pharmaceutical compositions comprising hypolipidemically active derivatives of 1,2,4-triazolidine-3,5-diones, 1,3,5-triazabicyclo[3.1.0]hexane-2,4-diones, and 1,3,5-triazine-2,4(1H,3H)-diones in a pharmaceutically acceptable carrier for treating hyperlipidemia in mammals, particularly humans. The present invention is also directed to a method of controlling hyperlipidemia in mammals which comprises administering to a mammal an amount effective to control hyperlipidemia of a compound having hypolipidemic activity and structural formula (I), wherein R is hydrogen, a C1 to C18 alkyl or substituted alkyl, a C2 to C18 alkenyl or substituted alkenyl, a C2 to C18 alkynyl or substituted alkynyl, a C4 to C10 cycloalkyl or substituted cycloalkyl, a C4 to C10 cycloalkenyl or substituted cycloalkenyl, phenyl, a substituted phenyl, cyano, phenalkyl, -CO-R or -Y-CO-R ; R is (a), (b), (c), R and R can be the same or different and are each the same as R ; R , R and R can be the same or different and are each hydrogen, a C1 to C18 alkyl or substituted alkyl, a C2 to C18 alkenyl or substituted alkenyl, a C1 to C18 alkynyl or substituted alkynyl, a C4 to C10 cycloalkyl or substituted cycloalkyl, a C4 to C10 cycloalkenyl or substituted cycloalkenyl, phenyl or substituted phenyl, phenalkyl, -CO-R , or -Y-CO-R , with the proviso that R5 and R together cannot be so bulky as to cause the compound to decompose; R is hydrogen, a C1 to C5 alkyl, a C4 to C10 cycloalkyl, -CO-R , or -Y-CO-R ; R is hydrogen, a C1 to C5 alkyl or substituted alkyl, a C2 to C5 alkenyl or substituted alkenyl, a C2 to C5 alkynyl or substituted alkynyl, phenyl or substituted phenyl, phenoxy or substituted phenoxy, a C1 to C5 alkoxy or substituted alkoxy, a C4 to C10 cycloalkyl or substituted cycloalkyl, a C4 to C10 cycloalkenyl or substituted cycloalkenyl, -NHC6C5, -NR R wherein R and R can be the same or different and are each hydrogen, a C1 to C5 alkyl or substituted alkyl, phenyl or substituted phenyl; Y is a C1 to C10 alkylene or substituted alkylene; R is -CO, -COH, -CS, -CSH, or a C1 to C4 alkylene group; and the pharmaceutically acceptable salts, and mixtures thereof.
    • 本发明提供药物组合物,其包含1,2,4-三唑烷-3,5-二酮,1,3,5-三氮杂双环[3.1.0]己烷-2,4-二酮的降血脂活性衍生物和1,3,5 - 三嗪-2,4(1H,3H) - 二酮在用于治疗哺乳动物,特别是人类的高脂血症的药学上可接受的载体中。 本发明还涉及一种控制哺乳动物高脂血症的方法,其包括向哺乳动物施用有效控制具有降血脂活性的化合物的高脂血症的量和结构式(I),其中R 1是氢,C1至 C18烷基或取代的烷基,C2至C18烯基或取代的烯基,C2至C18炔基或取代的炔基,C4至C10环烷基或取代的环烷基,C4至C10环烯基或取代的环烯基,苯基,取代的苯基,氰基, 苯基烷基,-CO-R 9或-Y-CO-R 9; R 2是(a),(b),(c),R 3和R 4可以相同或不同,并且各自与R 1相同; R 5,R 6和R 7可以相同或不同,各自为氢,C1至C18烷基或取代的烷基,C2至C18烯基或取代的烯基,C1至C18炔基或取代的 炔基,C4至C10环烷基或取代的环烷基,C4至C10环烯基或取代的环烯基,苯基或取代的苯基,苯基烷基,-CO-R9或-Y-CO-R9,条件是 R 5和R 6一起不能如此庞大,导致化合物分解; R 8是氢,C 1至C 5烷基,C 4至C 10环烷基,-CO-R 9或-Y-CO-R 9; R 9是氢,C 1至C 5烷基或取代的烷基,C 2至C 5烯基或取代的烯基,C 2至C 5炔基或取代的炔基,苯基或取代的苯基,苯氧基或取代的苯氧基,C 1至C 5的烷氧基或 取代的烷氧基,C 4至C 10环烷基或取代的环烷基,C 4至C 10环烯基或取代的环烯基,-NHC 6 C 5,-NR 10 R 11其中R 10和R 11可以相同或不同, 各自为氢,C1至C5烷基或取代的烷基,苯基或取代的苯基; Y是C1至C10亚烷基或取代的亚烷基; R 12是-CO,-COH,-CS,-CSH或C1〜C4亚烷基; 及其药学上可接受的盐及其混合物。
    • 10. 发明申请
    • PORTABLE AUTOMATED BLOOD PRESSURE MONITORING APPARATUS AND METHOD
    • 便携式自动血压监测装置及方法
    • WO1986003114A1
    • 1986-06-05
    • PCT/US1985002334
    • 1985-11-27
    • UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILLEUTECTIC ELECTRONICS, INC.HUTCHESON, Stanford, J.LUTZ, Richard, W.OBRIST, PaulFLAUGHER, David, J.WATTS, Charles, E.
    • UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILLEUTECTIC ELECTRONICS, INC.
    • A61B05/02
    • A61B5/02208
    • A portable computer-based blood pressure monitoring system automatically measures heart rate and blood pressure using the auscultatory method. Measurements are performed at random time intervals to prevent the subject from affecting his blood pressure and heart rate due to the expected onset of measurement. Data representative of Korotkoff sounds and corresponding applied cuff pressures is stored in both digital form in a semiconductor random access memory (132) and in analog form on a serial magnetic tape recorder (112). The system automatically maintains occluding cuff pressure constant for a predetermined period after cuff inflation before performing measurements to prevent pneumatic ringing from affecting blood pressure measurements. After cuff deflation, values are derived which are representatives of the average of the highest Korotkoff sound level peaks and the average of all Korotkoff sound level peaks and serve to define a threshold value in relation to which the points of systolic and diastolic pressure measurements are determined.
    • 基于便携式计算机的血压监测系统使用听诊方法自动测量心率和血压。 以随机时间间隔进行测量,以防止受试者由于预期的测量开始而影响他的血压和心率。 代表Korotkoff声音的数据和相应应用的袖带压力以数字形式存储在半导体随机存取存储器(132)中,并以模拟形式存储在串行磁带录像机(112)上。 在执行测量之前,系统在袖带充气之后的预定时间段内自动保持闭塞袖带压力恒定,以防止气动振铃影响血压测量。 袖带通缩后,导出值,这些值代表Korotkoff最高声级峰值的平均值和所有Korotkoff声级峰值的平均值,并用于定义相对于其中确定收缩压和舒张压测量点的阈值 。